Intrathecal Therapy for Chronic Pain: A Review of Morphine and Ziconotide as Firstline Options.
Cancer Pain
Firstline Intrathecal Therapy
Morphine
Noncancer Pain
Polyanalgesic Consensus Conference
Ziconotide
Journal
Pain medicine (Malden, Mass.)
ISSN: 1526-4637
Titre abrégé: Pain Med
Pays: England
ID NLM: 100894201
Informations de publication
Date de publication:
01 04 2019
01 04 2019
Historique:
pubmed:
24
8
2018
medline:
20
8
2019
entrez:
24
8
2018
Statut:
ppublish
Résumé
To evaluate the evidence for morphine and ziconotide as firstline intrathecal (IT) analgesia agents for patients with chronic pain. Medline was searched (through July 2017) for "ziconotide" or "morphine" AND "intrathecal" AND "chronic pain," with results limited to studies in human populations. The literature supports the use of morphine (based primarily on noncontrolled, prospective, and retrospective studies) and ziconotide (based on randomized controlled trials and prospective observational studies) as first-choice IT therapies. The 2016 Polyanalgesic Consensus Conference (PACC) guidelines recommended both morphine and ziconotide as firstline IT monotherapy for localized and diffuse chronic pain of cancer-related and non-cancer-related etiologies; however, one consensus point emphasized ziconotide use, unless contraindicated, as firstline IT therapy in patients with chronic non-cancer-related pain. Initial IT therapy choice should take into consideration individual patient characteristics (e.g., pain location, response to previous therapies, comorbid medical conditions, psychiatric history). Trialing is recommended to assess medication efficacy and tolerability. For both morphine and ziconotide, the PACC guidelines recommend conservative initial dosing strategies. Due to its narrow therapeutic window, ziconotide requires careful dose titration. Ziconotide is contraindicated in patients with a history of psychosis. IT morphine administration may be associated with serious side effects (e.g., respiratory depression, catheter tip granuloma), require dose increases, and cause dependence over time. Based on the available evidence, morphine and ziconotide are recommended as firstline IT monotherapy for cancer-related and non-cancer-related pain. The choice of first-in-pump therapy should take into consideration patient characteristics and the advantages and disadvantages of each medication.
Identifiants
pubmed: 30137539
pii: 5078133
doi: 10.1093/pm/pny132
pmc: PMC6442748
doi:
Substances chimiques
Analgesics, Non-Narcotic
0
Analgesics, Opioid
0
omega-Conotoxins
0
Morphine
76I7G6D29C
ziconotide
7I64C51O16
Types de publication
Journal Article
Review
Langues
eng
Pagination
784-798Informations de copyright
© 2018 American Academy of Pain Medicine.
Références
Neuromodulation. 2005 Jul;8(3):153-4
pubmed: 22151483
Pain Med. 2012 Oct;13(10):1304-13
pubmed: 22845187
Pain Med. 2004 Mar;5(1):6-13
pubmed: 14996232
Pain Pract. 2015 Mar;15(3):E34-9
pubmed: 25565390
Neuromodulation. 2010 Apr;13(2):109-13
pubmed: 21992783
Pain Physician. 2011 Jan-Feb;14(1):15-24
pubmed: 21267038
Pain Pract. 2018 Feb;18(2):230-238
pubmed: 28449352
Neuromodulation. 2015 Jul;18(5):414-20
pubmed: 25708382
Neuromodulation. 2003 Jul;6(3):142-52
pubmed: 22151017
J Pain. 2003 Jun;4(5):231-56
pubmed: 14622694
Neuromodulation. 2010 Apr;13(2):102-8
pubmed: 21992782
J Pain Symptom Manage. 2009 Mar;37(3):363-72
pubmed: 18715748
J Pain. 2003 Oct;4(8):441-7
pubmed: 14622664
Spine (Phila Pa 1976). 2002 Nov 15;27(22):2593-605; discussion 2606
pubmed: 12435999
Neuromodulation. 2008 Jan;11(1):40-9
pubmed: 22150990
Pain. 1992 Apr;49(1):21-5
pubmed: 1594278
Neuromodulation. 2017 Jun;20(4):386-391
pubmed: 27492135
Pain Med. 2016 Dec;17(12):2404-2421
pubmed: 28025375
Reg Anesth Pain Med. 2015 Jul-Aug;40(4):369-75
pubmed: 25923819
Pain Med. 2015 May;16(5):911-22
pubmed: 25376890
J Pain Res. 2014 Nov 10;7:627-38
pubmed: 25419158
South Med J. 1996 Mar;89(3):295-300
pubmed: 8604459
Pain Manag Nurs. 2013 Sep;14(3):e84-94
pubmed: 23972874
Surg Neurol. 2001 Feb;55(2):79-86; discussion 86-8
pubmed: 11301086
Anesthesiology. 2003 Jul;99(1):174-87
pubmed: 12826858
Neuromodulation. 2014 Jun;17(4):354-72; discussion 372
pubmed: 24446870
Pain Physician. 2011 Jul-Aug;14(4):343-51
pubmed: 21785477
Pain Manag. 2015;5(3):175-83
pubmed: 25971641
J Pain Symptom Manage. 1996 Feb;11(2):71-80
pubmed: 8907137
Neuromodulation. 2017 Feb;20(2):96-132
pubmed: 28042904
Anesth Analg. 2005 Jun;100(6):1740-5
pubmed: 15920207
JAMA. 2004 Jan 7;291(1):63-70
pubmed: 14709577
Neuromodulation. 1999 Apr;2(2):55-66
pubmed: 22151109
MMWR Morb Mortal Wkly Rep. 2011 Nov 4;60(43):1487-92
pubmed: 22048730
J Neurosurg. 1987 Aug;67(2):182-6
pubmed: 3598678
Am J Prev Med. 2001 Apr;20(3 Suppl):21-35
pubmed: 11306229
N Engl J Med. 2015 Jan 15;372(3):241-8
pubmed: 25587948
Neuromodulation. 2007 Apr;10(2):167-76
pubmed: 22151867
MMWR Morb Mortal Wkly Rep. 2016 Dec 30;65(50-51):1445-1452
pubmed: 28033313
Neuromodulation. 2005 Apr;8(2):112-20
pubmed: 22151440
Pain Pract. 2008 May-Jun;8(3):164-70
pubmed: 18384501
Korean J Pain. 2013 Jan;26(1):32-8
pubmed: 23342205
J Pain Symptom Manage. 2006 May;31(5):393-406
pubmed: 16716870
Pain Pract. 2018 Mar;18(3):305-313
pubmed: 28520273
Anesthesiology. 2009 Oct;111(4):881-91
pubmed: 20029253
Neuromodulation. 2003 Jul;6(3):133-41
pubmed: 22151016
J Pain Symptom Manage. 2007 Nov;34(5):547-65
pubmed: 17900855
Neuromodulation. 2017 Feb;20(2):133-154
pubmed: 28042906
J Pain Res. 2014 Nov 06;7:615-26
pubmed: 25395870
Anesth Analg. 2009 Dec;109(6):1981-6
pubmed: 19923529
Pain Physician. 2011 May-Jun;14(3):E283-312
pubmed: 21587338
Neuromodulation. 2016 Jul;19(5):522-32
pubmed: 26856969
Neuromodulation. 2013 Nov-Dec;16(6):576-81; discussion 582
pubmed: 23205907
Neuromodulation. 2006 Apr;9(2):75-86
pubmed: 22151630
Curr Neuropharmacol. 2017;15(2):206-216
pubmed: 26861471
Anesthesiology. 2010 Jan;112(1):165-73
pubmed: 19996952
J Clin Endocrinol Metab. 2000 Jun;85(6):2215-22
pubmed: 10852454
Curr Pain Headache Rep. 2014 Jan;18(1):388
pubmed: 24338701
Neuromodulation. 2016 Feb;19(2):206-19
pubmed: 26477685
Neuromodulation. 2012 Sep-Oct;15(5):420-35; discussion 435
pubmed: 22494357
J Clin Oncol. 2002 Oct 1;20(19):4040-9
pubmed: 12351602
Pain Med. 2011 Aug;12(8):1179-89
pubmed: 21810164
Neuromodulation. 2017 Feb;20(2):155-176
pubmed: 28042914
Neuromodulation. 1999 Apr;2(2):92-107
pubmed: 22151113
J Neurosurg. 1990 Feb;72(2):200-9
pubmed: 1688618
Pain Physician. 2007 Mar;10(2):357-66
pubmed: 17387357
Acta Neurochir Suppl. 2011;108:41-7
pubmed: 21107937
Pain Med. 2015 Jul;16(7):1265-77
pubmed: 25645109
J Neurosurg. 1996 Sep;85(3):458-67
pubmed: 8751633
Pain. 2012 Jan;153(1):245-9
pubmed: 22082570
Am J Hosp Palliat Care. 2012 Aug;29(5):409-11
pubmed: 21868426
Neurosurgery. 1999 Feb;44(2):289-300; discussion 300-1
pubmed: 9932882
Pain Pract. 2016 Nov;16(8):1092-1106
pubmed: 26914961
BMJ Open. 2013 Jul 31;3(7):
pubmed: 23903811